Mar 06, 2025 9:01am EST HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
Feb 27, 2025 8:31am EST HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
Feb 25, 2025 4:01pm EST HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
Feb 13, 2025 8:31am EST HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
Jan 29, 2025 8:31am EST HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
Dec 16, 2024 8:31am EST HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
Nov 19, 2024 8:31am EST HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference